2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
JBS N.V. submitted a non-binding proposal to Pilgrim's Pride's board to acquire all PPC shares it does not already own, in exchange for 2.086 JBS Class A shares per PPC share. JBS owns about 82% of PPC, and the filing says there is no guarantee a binding agreement will be reached. For PPC minority shareholders, the proposal would replace their PPC shares with JBS shares and end PPC's public listing if completed.
Exchange ratio of 2.086 JBS Class A shares per PPC share, based on August 18, 2026 closing prices of $13.66 for JBS and $28.49 for PPC
JBS currently owns approximately 82% of PPC common stock
Proposal requires approval by a special committee of independent directors and a majority of votes cast by unaffiliated PPC shares; it is not binding
If completed, PPC shares would stop trading on Nasdaq and be deregistered
Nasdaq notified Skye Bioscience on August 18, 2026 that its stockholders' equity of ($497,307), as reported in its June 30, 2026 quarterly report, falls short of the $2,500,000 minimum under Nasdaq Capital Market Listing Rule 5550(b)(1). The notice has no immediate effect on the listing, and the stock continues to trade as SKYE, but the company must submit a plan to regain compliance and says there is no assurance it will do so. The notice comes alongside a pending acquisition of Redx Pharma Limited, which adds uncertainty for shareholders.
Stockholders' equity was ($497,307) versus a $2,500,000 minimum under Nasdaq Listing Rule 5550(b)(1)
Stock continues to trade on the Nasdaq Capital Market under SKYE; the notice has no immediate effect on listing
Compliance plan due October 2, 2026; if accepted, Nasdaq can grant an extension to February 14, 2027
Company is evaluating alternatives and says there can be no assurance it will regain compliance; Redx transaction agreement is dated August 14, 2026
Backblaze announced its intention to offer $150 million of Convertible Senior Notes due 2031 in a private offering to qualified institutional buyers, subject to market conditions, with an option for initial purchasers to buy up to $22.5 million more. The company plans to use part of the proceeds for capped call transactions, which are expected to reduce potential dilution to Class A shareholders upon conversion, and the rest for general corporate purposes, including capital expenditures. The filing also discloses a Fourth Credit Agreement amendment with Citizens Bank, N.A., and a planned Fifth Amendment that would raise the revolving credit facility from $20 million to $50 million, and the interest rate and conversion terms of the notes have not yet been set.
Offering of $150 million aggregate principal of Convertible Senior Notes due 2031, with a 13-day option for up to an additional $22.5 million
Net proceeds to fund capped call transactions, with the remainder for general corporate purposes including capital expenditures
Planned Fifth Amendment would raise the revolving credit facility from $20 million to $50 million and extend its maturity from June 4, 2028 to April 30, 2030
Wrap Technologies, Inc. closed a registered direct offering on August 18, 2026, selling 8,571,609 shares of common stock or pre-funded warrants in lieu of shares at $1.40 per share. Gross proceeds were approximately $12.0 million before placement agent fees and other offering expenses, and the company plans to use them for working capital and general corporate purposes. Shareholders should note that the sale adds new shares to the count, which can dilute existing holders.
Offering closed August 18, 2026; the purchase agreement was signed August 16, 2026.
Total of 8,571,609 shares: 5,771,519 common shares plus pre-funded warrants for up to 2,800,090 shares, priced at $1.40 per share ($1.3999 per pre-funded warrant).
Gross proceeds of approximately $12.0 million before offering expenses; Maxim Group LLC was the sole placement agent.
Securities were sold under a Form S-3 shelf registration declared effective December 18, 2025.
Blue Owl Finance LLC, an indirect subsidiary of Blue Owl Capital Inc. (OWL), completed a $750 million offering of 6.750% senior notes maturing August 18, 2036. The notes are fully and unconditionally guaranteed by Blue Owl Capital Inc. and several of its subsidiaries, which adds a new long-term debt obligation for the company group.
Principal amount: $750 million; interest at 6.750% per year, paid semi-annually from February 18, 2027
Maturity date: August 18, 2036; redeemable at the issuer's option, with 100% of principal from May 18, 2036
Notes are unsecured, guaranteed jointly and severally by the parent and multiple subsidiaries; change of control repurchase at 101%
Issued under a 2024 indenture with Wilmington Trust, National Association, as trustee; underwriters are BofA Securities, Goldman Sachs and Morgan Stanley
Baxter entered into Amendment No. 2 to its credit agreement on August 18, 2026, raising the maximum net leverage ratio for five fiscal quarters ending September 30, 2026 through September 30, 2027, and removing Baxter World Trade SRL as a borrower. The same day, the company raised the aggregate purchase price cap on its cash tender offers for certain senior notes from $500 million to $600 million and said it expects to accept $600 million of tendered notes for settlement on August 20, 2026.
Amendment No. 2, dated August 18, 2026, raises the maximum net leverage ratio covenant for the five fiscal quarters ending September 30, 2026 through September 30, 2027.
The tender offer purchase price cap rose from $500 million to $600 million, excluding accrued interest.
Holders who tendered by 5:00 p.m. New York City time on August 17, 2026 and were accepted receive an early tender premium of $30 per $1,000 principal amount, with early settlement on August 20, 2026.
Tenders for the 2.539% Senior Notes due 2032 totaled $756,712,000 of $1,550,000,000 outstanding, and the proration factor for that series is 31.37%.
Martin Marietta entered into a $1.5 billion five-year senior unsecured revolving credit facility with JPMorgan Chase Bank, N.A. as administrative agent, replacing its existing credit agreement dated December 21, 2021. The filing states that no borrowings were outstanding under the existing facility before the new agreement, and the new facility expires August 18, 2031. The filing also sets a leverage ratio covenant that steps up to 4.75 to 1.00 after the closing of the previously announced Lhoist North America acquisition, which gives the company more room under the covenant during that period.
$1.5 billion senior unsecured revolving facility, dated August 18, 2026, with JPMorgan Chase Bank, N.A. as administrative agent
Replaces the Existing Credit Agreement dated December 21, 2021; no borrowings were outstanding under it before the new facility
Facility expires August 18, 2031; interest is based on Term SOFR or a base rate plus a ratings-based margin
Maximum leverage ratio of 3.75 to 1.00, rising to 4.75 to 1.00 for the first three fiscal quarters after the Lhoist North America acquisition closes
WaterBridge's subsidiary WBI Operating LLC completed a private placement of an additional $150 million of 6.500% senior notes due 2033, upsized from an initial $100 million. The company plans to use the net proceeds to repay part of its revolving credit facility, and the new notes are part of the same series as the $600 million of existing notes.
Additional $150 million aggregate principal of 6.500% senior notes due 2033 completed on August 18, 2026, after pricing was announced August 13, 2026
Offering was upsized from an initial $100 million
Net proceeds intended to repay a portion of outstanding revolving credit facility borrowings
Notes are guaranteed by the issuer's existing subsidiaries on a senior unsecured basis and were sold under Rule 144A and Regulation S
Centrus Energy's Compensation, Nominating & Governance Committee approved a one-time grant of performance-based restricted stock units to executive officers and certain senior leaders on August 15, 2026, under a new 2026 Supplemental Executive Incentive Plan. The awards vest only if the company meets specified milestones, including completing a first cascade at its Piketon, Ohio facility and achieving enrichment from a first cascade, and are forfeited if employment ends before vesting.
Grant approved August 15, 2026 under the 2026 Plan, which sits under the 2014 Equity Incentive Plan
CEO Amir V. Vexler's awards, valued at $5,000,000 at full achievement, vest 100% on the Final Milestone
Other named executive officers' awards vest 30% on the first cascade at Piketon, Ohio and 70% on the Final Milestone; named officers' values range from $1,300,000 to $2,000,000 at full achievement
Award agreements will be filed as exhibits to the Form 10-Q for the quarter ending September 30, 2026
Sezzle and WebBank entered into amended bank program agreements on August 12, 2026, adding two products, SezzleCash and Sezzle Send, to the existing loan program. For those two products WebBank will keep loans on its balance sheet up to an initial $30.0 million threshold, which it may raise to $150.0 million, and Sezzle's minimum tangible net worth requirement rises from $12.0 million to $100.0 million.
Agreements dated August 12, 2026 amend and restate the September 26, 2024 bank program agreements with WebBank.
WebBank will retain SezzleCash and Sezzle Send loans to maturity, with an initial retention threshold of $30.0 million, which WebBank may raise up to $150.0 million.
Minimum tangible net worth covenant increases from $12.0 million to $100.0 million; new termination events added for judgments, fines or penalties and financial covenant breaches.
Program term is unchanged and runs through September 27, 2029; full agreements to be filed with the Form 10-Q for the quarter ending September 30, 2026.
Foxx Development Holdings Inc. disclosed that Chief Technology Officer James Liao resigned effective August 14, 2026, from the parent company and from its operating subsidiary, Foxx Development Inc. The company said he resigned for personal reasons and not because of any disagreement over operations, policies or practices.
James Liao resigned as Chief Technology Officer effective August 14, 2026
He also resigned as Chief Technology Officer of operating subsidiary Foxx Development Inc.
The company says the resignation was for personal reasons, not a disagreement with the company
The filing was signed by CFO Joy Yi Hua on August 18, 2026
Iridex reported second-quarter 2026 revenue of $12.6 million, down 7% from a year earlier, as lower retina sales outweighed growth in its Cyclo G6 glaucoma products. The net loss widened to $1.3 million, or $0.07 per share, from $1.0 million, or $0.06 per share, and the company reaffirmed its full-year 2026 revenue guidance of $51 million to $53 million.
Total revenue was $12.6 million, compared with $13.6 million in the prior-year quarter; retina product revenue fell to $6.5 million from $8.0 million.
Cyclo G6 product family revenue rose 19% to $3.9 million, with 17,700 probes sold versus 13,100 a year earlier.
Net loss was $1.3 million, or $0.07 per share, versus $1.0 million, or $0.06 per share, in the second quarter of 2025.
Full-year 2026 revenue guidance of $51 million to $53 million was reaffirmed; adjusted operating expense guidance is $19 million to $19.5 million.
Toll Brothers reported fiscal third-quarter 2026 results for the period ended July 31, 2026, with net income of $280.1 million, or $2.97 per diluted share, down from $369.6 million, or $3.73, a year earlier. Home sales revenues fell to $2.65 billion from $2.88 billion, and the company reaffirmed its full-year guidance while raising its projected fiscal 2026 share repurchases to $700 million from $650 million.
Net income was $280.1 million, or $2.97 per diluted share, versus $369.6 million, or $3.73, in the prior-year third quarter.
Home sales revenues were $2.65 billion on 2,662 delivered homes, compared with $2.88 billion on 2,959 homes a year earlier.
Home sales gross margin was 23.9%, versus 25.6%; adjusted home sales gross margin was 25.6%, versus 27.5%.
Full-year fiscal 2026 guidance was reaffirmed, including about $10.5 billion of home sales revenues, and projected share repurchases were raised to $700 million.
Jack Henry reported fourth-quarter and full-year fiscal 2026 results for the period ended June 30, 2026. Full-year GAAP revenue and diluted EPS rose, but fourth-quarter GAAP operating income and EPS declined from the prior year quarter. The company also issued fiscal 2027 GAAP EPS guidance of $7.33 to $7.38, which assumes no acquisitions or dispositions, and it spent $448 million on stock repurchases during the fiscal year.
Fourth-quarter GAAP revenue rose 4.7% to $644 million, while GAAP operating income fell 12.2% to $137 million and GAAP EPS fell to $1.57 from $1.75.
Full-year GAAP revenue rose 7.1% to $2.54 billion, and GAAP EPS rose 11.9% to $6.98 from $6.24.
Fiscal 2027 GAAP revenue guidance is $2,684 million to $2,709 million, and GAAP EPS guidance is $7.33 to $7.38.
Stock repurchases were $448 million for the fiscal year at an average price of $152 per share, including $164 million in the fourth quarter at $140 per share.
On August 18, 2026, EXL entered a $1 billion senior secured credit facility with PNC Bank as administrative agent, consisting of a $600 million revolver and a $400 million term loan that mature August 18, 2031. The company used the proceeds to repay about $532,678,050 under its Citibank credit agreement, which it terminated with no early termination penalties. The larger facility increases borrowing capacity and covenant flexibility, with proceeds available for working capital, acquisitions and share buybacks.
Facilities total $1 billion: a $600 million revolving credit facility and a $400 million term loan, both maturing August 18, 2031
Repaid about $532,678,050 under the Citibank credit agreement, terminated with no early termination penalties
Borrowings bear interest at Term SOFR or Daily Simple SOFR plus a 1.00% to 1.75% margin, set by total net leverage
Covenants require interest coverage of at least 3.00 to 1.00 and total net leverage of no more than 3.50 to 1.00; obligations are secured by substantially all company assets
IDT Telecom, a subsidiary of IDT Corporation, signed an amendment dated August 11, 2026 to its revolving credit agreement with TD Bank, N.A. The amendment extends the facility, which was due to mature on August 16, 2026, to July 15, 2029, and raises the bank's lending limit in May and December, which could affect how much credit is available to the subsidiary during those months.
Maturity of the revolving credit facility extended from August 16, 2026 to July 15, 2029.
Revolving credit limit increased to $50.0 million in May and December of each calendar year, from $25.0 million in all other months.
National Retail Solutions, Inc., IDT Payment Services, Inc. and IDT Payment Services of New York, LLC added as corporate guarantors.
Credit facility remains secured by assets of IDT Telecom and several affiliates; other material terms are unchanged.
Beyond Air reported revenue of $1.8 million for the quarter ended June 30, 2026, unchanged from the prior-year quarter, while its net loss attributable to common stockholders widened to $7.9 million from $7.7 million. The company reaffirmed its calendar 2026 revenue guidance of $8 million and its 2027 guidance of $16-$18 million, and disclosed a financing of up to $30.1 million, including $10.2 million in upfront gross proceeds, which it said will fund international expansion and a U.S. launch pending FDA approval.
Revenue was $1.8 million in both the quarter ended June 30, 2026 and the same quarter of 2025; gross margin rose to 13% from 9%.
Net loss attributable to common stockholders was $7.9 million, or $11.00 per share, versus $7.7 million, or $30.67 per share, a year earlier; per-share figures reflect a one-for-twenty stock split in July 2026.
Cash, cash equivalents, restricted cash and marketable securities totaled $15.2 million at June 30, 2026, before the financing of up to $30.1 million announced after quarter-end.
The company said it regained compliance with Nasdaq's minimum bid price requirement and that the FDA review of the second-generation LungFit PH PMA supplement is pending, with approval expected in the second half of calendar 2026.
Blue Water Acquisition Corp. IV, a blank-check company, appointed Nadab Akhtar to its board of directors effective August 12, 2026, as a Class I director. The board determined he is independent and placed him on its audit, compensation, and nominating and corporate governance committees.
Appointment effective August 12, 2026, made by Blue Water Acquisition IV LLC, sole holder of Class B ordinary shares.
Akhtar is Founder and Managing Partner of Excite Capital and Co-Founder and CEO of Project LightShift.
He joins the audit, compensation, and nominating and corporate governance committees.
The filing states no family relationships with directors or officers and no arrangement under which he was appointed.
AbbVie completed an underwritten offering of nine series of senior notes on August 18, 2026, totaling $10.0 billion in principal across floating rate notes maturing 2028 and fixed rate notes maturing 2028 through 2066. AbbVie expects to use the net proceeds to fund part of the cash consideration for its acquisition of Apogee Therapeutics and related fees, with any remainder for general corporate purposes.
Nine series of notes totaling $10.0 billion in aggregate principal, registered under AbbVie's Form S-3ASR dated February 14, 2025
Net proceeds to fund a portion of the cash consideration due to Apogee shareholders and related fees and expenses
If the Apogee acquisition is terminated or abandoned, AbbVie must redeem most series (not the 2056 or 2066 Notes) at 101% of principal plus accrued interest
Notes are unsecured and rank equally with AbbVie's existing and future unsecured, unsubordinated debt
Agenus and its subsidiary Agenus West amended a loan from Ocean 1181 LLC, with the outstanding principal unchanged at $24,750,000 and maturity extended to November 30, 2029. The loan carries a 13.0% annual interest rate, and interest and a $247,500 extension fee will be paid partly in newly issued common stock, which adds potential dilution for shareholders.
Outstanding principal remains $24,750,000; maturity extended to November 30, 2029
Interest rate of 13.0% per annum through maturity; monthly interest payable one-half in cash and one-half in common stock
Extension fee of $247,500, payable one-half in cash and one-half in common stock
Agreement signed August 12, 2026; shares to be issued to the lender in exempt private transactions
Charter's subsidiaries Charter Communications Operating, LLC and Charter Communications Operating Capital Corp. closed a $4.75 billion offering of four series of senior secured notes on August 18, 2026. The filing says the notes are senior secured obligations guaranteed by the parent and subsidiary guarantors, and that the offering was made under an automatic shelf registration.
Four series issued: $1.75 billion 6.050% notes due 2032, $1.0 billion 6.600% notes due 2034, $1.0 billion 6.950% notes due 2036 and $1.0 billion 7.850% notes due 2056
Issue prices ranged from 99.839% to 99.937% of principal amount
Interest is payable each February 15 and August 15, starting February 15, 2027
Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC were joint book-running managers
Trio Petroleum Corp's board approved a one-for-nine reverse stock split of its common stock, to take effect at 4:30 p.m. Eastern Time on August 28, 2026, with split-adjusted trading starting August 31, 2026. The company says the split is intended to protect its NYSE American listing in light of potential changes to exchange listing rules, and it states the split is not a change in its business strategy.
Every nine outstanding shares will combine into one share; the ratio falls within the one-for-two to one-for-ten range approved by stockholders on May 21, 2026.
Stockholders holding fractional shares will receive cash in lieu, based on the NYSE American closing price on the effective date.
The new CUSIP number will be 89669L306, and the stock will keep the TPET symbol.
As of April 30, 2026, the company had about $22 million in cash; it has raised about $1.7 million through its at-the-market facility since then.
La-Z-Boy reported fiscal first-quarter 2027 results for the period ended July 25, 2026. Sales fell 3% to $476 million, GAAP results swung to a loss of $(0.06) per diluted share from $0.44 a year earlier, and adjusted diluted EPS fell to $0.43 from $0.47, while Retail written sales rose 16%. The company also gave second-quarter sales guidance of $500-$520 million and an adjusted operating margin of 4.0-5.5%.
Consolidated sales of $475.7 million fell 3% from $492.2 million; Wholesale sales fell 9% to $323 million, while Retail delivered sales rose 10% to $229 million
GAAP diluted EPS was $(0.06) versus $0.44; adjusted diluted EPS was $0.43 versus $0.47, with adjustments mainly for $17.6 million of charges tied to exiting two smallest plants
Second-quarter outlook: sales of $500-$520 million and adjusted operating margin of 4.0-5.5%
Board declared a quarterly dividend of $0.242 per share, payable September 15, 2026, to holders of record on September 3, 2026; the company returned $35 million to shareholders in the quarter
Reservoir Media filed an investor presentation on August 18, 2026, that reports first-quarter fiscal 2027 results and issues a fiscal 2027 outlook. Total revenue grew 12% year over year and adjusted EBITDA grew 13%, while net debt stood at $448 million as of June 30, 2026. The presentation states that its financial information is unaudited and preliminary.
Q1 fiscal 2027 total revenue up 12% year over year; Music Publishing up 6% and Recorded Music up 35%
Q1 adjusted EBITDA up 13% year over year for the quarter
Fiscal 2027 outlook: revenue $186 million-$191 million (7% growth at midpoint); adjusted EBITDA $75 million-$79 million (5% growth at midpoint)
As of June 30, 2026: total debt $462 million, cash $14 million, net debt $448 million
AXIL Brands reported fourth-quarter and fiscal 2026 results for periods ended May 31, 2026. Q4 net revenues rose 48.9% to a record $8.6 million, and net income was $1.5 million, or $0.18 per diluted share, compared with a loss in the prior-year quarter. For the full year, net income was $2.7 million, or $0.33 per diluted share, versus $0.10 in fiscal 2025, and the company reported no outstanding borrowings as of May 31, 2026.
Q4 2026 net revenues were $8.6 million, up from $5.8 million a year earlier, driven mainly by sales to big box retail chains
Q4 2026 gross margin was 72.0%, up from 70.0%; net income was $1.5 million, or $0.18 per diluted share, versus a $0.04 per share loss
Fiscal 2026 net income was $2.7 million, or $0.33 per diluted share, compared with $0.10 per diluted share in fiscal 2025
Cash was $4.5 million as of May 31, 2026, versus $4.8 million a year earlier; the company received about $910,000 in IEEPA duty refunds after year end, to be recorded in fiscal 2027
Wisconsin Electric Power Company, a WEC Energy subsidiary, agreed on August 14, 2026 to buy 86% of the capacity, energy, ancillary services and environmental attributes from Units 1 and 2 of the Point Beach Nuclear Power Plant under a 20-year power purchase agreement. The deal still needs approval from the Public Service Commission of Wisconsin, and the company says approval would bring customer savings compared with the current agreement.
Agreement signed August 14, 2026 with NextEra Energy Point Beach LLC covering 86% of Point Beach Units 1 and 2
Unit 1 term runs October 6, 2030 through October 5, 2050; Unit 2 term runs March 9, 2033 through March 8, 2053
Either party may terminate if PSCW approval is not obtained by January 1, 2028, with an automatic extension to July 1, 2028 in certain cases
Approval would replace the current agreement, which expires October 5, 2030 for Unit 1 and March 8, 2033 for Unit 2
Keysight reported preliminary third-quarter fiscal 2026 results for the period ended July 31, 2026, with revenue of $1.85 billion and GAAP net income of $397 million, or $2.30 per share, compared with $1.35 billion and $1.10 per share a year earlier. The company also expects fourth-quarter revenue of $1.930 billion to $1.950 billion and non-GAAP earnings of $3.34 to $3.40 per share.
Q3 revenue was $1.85 billion, up from $1.35 billion in the third quarter of 2025; orders were $2.09 billion.
GAAP diluted EPS was $2.30 versus $1.10 a year earlier; non-GAAP diluted EPS was $3.07 versus $1.72.
Fourth-quarter fiscal 2026 guidance: revenue of $1.930 billion to $1.950 billion and non-GAAP EPS of $3.34 to $3.40.
Free cash flow was $403 million in the quarter, compared with $291 million a year earlier.
Liminatus Pharma said it will carry out a 1-for-50 reverse stock split of its common stock, effective August 20, 2026, so its shares can meet Nasdaq's $1.00 minimum bid price. The company remains listed under a Nasdaq Panel exception, but it must show a $1.00 closing bid for at least ten consecutive trading days by September 3, 2026, and the company says it cannot assure it will do so.
Reverse split ratio of 1-for-50, with split-adjusted trading under LIMN on The Nasdaq Capital Market expected at the market open on August 21, 2026
New CUSIP number 53271X 207; fractional shares will be rounded up to the nearest whole share, with no cash paid for fractions
Based on July 2, 2026 figures, outstanding shares would fall from 67,160,362 to approximately 1,343,208
Nasdaq Panel extended the deadline to demonstrate compliance with Listing Rule 5550(a)(2) to September 3, 2026
374Water reported second-quarter 2026 revenue of $2.26 million, up from about $0.6 million a year earlier, driven mainly by the Orange County Sanitation District Factory Acceptance Test. The net loss narrowed to $2.7 million, or $0.15 per share, from $4.6 million, or $0.32 per share, while cash and cash equivalents were $1.8 million as of June 30, 2026, which shareholders may weigh against continued cash use.
Q2 2026 revenue was $2.26 million vs. about $0.6 million in Q2 2025, with gross margin of 87%.
Net loss was $2.7 million, or $0.15 per share, vs. $4.6 million, or $0.32 per share, in Q2 2025.
Cash used in operations was $2.3 million for the six months ended June 30, 2026, vs. $7.6 million a year earlier; cash was $1.8 million at June 30, 2026.
The company cites annualized operating cost reductions of about $3.2 million and $2.6 million of remaining OC San contract value to be invoiced.
On August 12, 2026, Singularity Future Technology amended its June 19, 2025 securities purchase agreement with eighteen investors and issued them 2,299,212 common shares under Regulation S. The amendment also commits the company to issue amended and restated warrants exercisable at $0.001 per share, and those warrants will not be issued until shareholder approval is obtained.
Issued 2,299,212 common shares to the Investors on August 12, 2026, on the post-1:14-reverse-split basis.
Original June 19, 2025 placement covered 32,188,841 units pre-split (2,299,212 post-split) for gross proceeds of approximately $30 million.
Amended and restated warrants would be exercisable at $0.001 per share, versus the original $16.310 post-split exercise price.
Amended warrant issuance requires shareholder approval; the filing does not state a date for that vote.
Diodes completed a private offering of $375 million of 0.00% convertible senior notes due August 15, 2031, including the full exercise of a $50.0 million option, and amended its senior credit agreement to extend the revolver maturity to August 12, 2031 and permit the new debt. The notes carry a conversion price of about $145.79 per share, a 50.0% premium to the $97.19 closing price on August 13, 2026, so the offering adds debt that may dilute shareholders if the stock rises above that level.
Offering of $375 million principal closed August 18, 2026, including $50.0 million from the full exercise of the initial purchasers' option
Notes mature August 15, 2031; no regular interest; conversion price about $145.79 per share
Net proceeds estimated at $364.6 million with the option exercised, after costs; $35.0 million used to repurchase about 0.36 million shares at $97.19
Credit agreement amendment, effective August 12, 2026, extends revolver maturity to August 12, 2031 and changes pricing and covenants
Bridgeline Digital reported fiscal third-quarter 2026 results for the quarter ended June 30, 2026. Total revenue rose to $3.9 million from $3.8 million a year earlier, and the net loss narrowed to $0.5 million from $0.8 million, though gross margin fell to 64% from 66%. For the nine months, revenue rose to $11.8 million and the net loss narrowed to $1.0 million from $2.2 million.
Q3 total revenue was $3.9 million, up from $3.8 million in the prior-year quarter; subscription revenue was flat at $3.1 million.
Q3 net loss was $0.5 million, compared with $0.8 million a year earlier; operating loss was $0.5 million versus $0.7 million.
Gross margin was 64% versus 66% a year earlier; operating expenses fell to $3.0 million from $3.2 million.
Nine-month net loss was $1.0 million, compared with $2.2 million in the prior-year period.
Mercury Systems reported fourth-quarter and fiscal 2026 results for the period ended July 3, 2026. Revenue grew, and bookings and backlog hit company records, but fourth-quarter GAAP net income fell to $1 million from $16 million a year earlier, and management said it is increasing its organic growth outlook without giving new figures.
Q4 fiscal 2026 revenue was $290 million, up from $273 million; bookings were $660 million, up 93.1%
Q4 GAAP diluted EPS was $0.01 versus $0.27 a year earlier; adjusted EBITDA was $49 million versus $51 million
Full-year revenue rose to $984 million from $912 million; GAAP net loss narrowed to $30 million ($0.50 per share) from $38 million
Backlog exceeded $1.9 billion, up 38.4% year over year; management said it is increasing its outlook for organic growth
Catalyst Bank entered into a new employment agreement with President and CEO Joseph B. Zanco on August 17, 2026, running through August 17, 2029. The filing sets a $350,000 base salary and includes enhanced severance and change-in-control terms, so shareholders should note the potential cost if his employment ends.
New agreement term runs August 17, 2026 to August 17, 2029, unless renewed or extended.
Base salary of $350,000, which the board may increase at its discretion.
Severance on involuntary termination: 12 months of base salary; 36 months if terminated within 30 days after a change in control.
Flexible Solutions International reported a second-quarter 2026 net loss of $1,912,967, or $0.15 per share, versus net income of $2,028,912, or $0.16 per share, a year earlier. Sales fell about 14% to $7,610,148, and management said scale-up costs for food-grade and Panama operations outweighed revenue so far, with the company expecting a return to profitability in Q3 2026.
Q2 2026 sales were $7,610,148, down about 14% from $8,867,132 in Q2 2025, which included a $2.5 million R&D payment not repeated in 2026.
Q2 2026 net loss was $1,912,967 ($0.15 per share), compared with net income of $2,028,912 ($0.16 per share) in Q2 2025.
Management guided that Panama revenue could reach $3 million, ENP revenue could exceed $5 million, and NanoChem revenue could exceed $4 million in Q3 2026.
Management expects to raise prices to customers in the third or fourth quarter unless oil prices fall significantly.
Rexford Industrial Realty agreed on August 13, 2026 to sell a portfolio of 22 industrial properties to an affiliate of EQT Real Estate for about $1.2 billion in cash, subject to customary closing adjustments. The sale is part of a previously announced $2.0 billion disposition program of non-core assets, and the company reaffirmed its 2026 guidance. Shareholders will watch whether the closing occurs by the expected September 30, 2026 date and how the net proceeds are used.
22 industrial properties, aggregate purchase price of about $1.2 billion payable in cash at closing
Closing expected by September 30, 2026; not subject to a due diligence condition
Company says the deal brings 2026 dispositions closed or under contract to about $1.5 billion, within its $1.5 to $2.0 billion full-year guidance range
Net proceeds may fund repayment of debt maturing in 2027 and repurchases under the $1.0 billion share repurchase program
On August 12, 2026, Universal Technical Institute entered a five-year senior secured revolving credit agreement with Fifth Third Bank and four other lenders, replacing its existing credit agreement in full. The new facility is larger than the prior $125 million facility and matures in August 2031, and the company's subsidiaries guarantee the debt and secure it with their assets, subject to certain exceptions.
Facility of up to $200 million, up from $125 million in the existing facility, with a $15 million swingline sublimit and a $75 million letter of credit sublimit
Uncommitted incremental capacity of up to $75 million in aggregate; facility matures in August 2031
Xylem said CFO William Grogan will resign effective August 31, 2026 to pursue another opportunity, and Andrea van der Berg, currently SVP Finance for the Water Infrastructure segment, will become CFO on September 1, 2026. Xylem also reaffirmed its third-quarter and full-year 2026 guidance issued July 28, 2026, which matters to shareholders because it signals no change to the outlook alongside the finance leadership change.
Grogan remains employed through September 13, 2026 to support the transition.
Van der Berg's annual base salary is $675,000, with an AIP target of 80% of base salary.
Van der Berg receives a one-time 2026 LTIP award with a grant date value of $787,500, and a new LTIP target award of $1,750,000.
Xylem reaffirmed its third-quarter and full-year 2026 guidance issued July 28, 2026.
GE HealthCare appointed William K. Grogan, currently executive vice president and CFO of Xylem Inc., as Chief Financial Officer effective September 14, 2026, succeeding interim CFO George Newcomb, who will remain Controller and Chief Accounting Officer. The filing sets out his pay package, including a $900,000 base salary, a 100% target bonus, and sign-on awards to offset compensation forfeited at Xylem, which matters to shareholders as it defines the company's new top finance executive and its compensation commitments.
Grogan, age 48, has been Xylem's EVP and CFO since October 2023 and was IDEX Corporation's CFO from January 2017 to September 2023.
Offer letter: $900,000 base salary, target annual bonus of 100% of salary, and a 2026 annual LTI award with a $3,300,000 target grant date value.
Sign-on payments include $550,000 in cash and a $4,000,000 RSU award, with cash repayment required if he resigns within two years.
Newcomb ceases as interim CFO on September 14, 2026, and continues as Controller and Chief Accounting Officer.
BioMarin agreed on August 17, 2026 to acquire Alesta Therapeutics, a Dutch clinical-stage biotech, for a $275 million upfront cash payment plus up to $215 million in future payments tied to development milestones. Alesta will first spin out its non-ALE1 assets, and BioMarin expects to fund the deal with cash on hand and to update its full-year 2026 guidance after closing; the company says the deal is expected to be modestly dilutive to 2026 results excluding the upfront payment.
Upfront cash payment of $275 million, subject to a customary post-closing price adjustment, plus up to $215 million in milestone-based payments
Lead asset ALE1 is an oral small molecule in a Phase 1/2a trial for hypophosphatasia, a rare genetic bone disease
Closing expected in the third quarter of 2026, subject to closing conditions; BioMarin plans to fund the deal with cash on hand
Filing states the deal is expected to be modestly dilutive to 2026 results, excluding the upfront consideration
QT Imaging posted a mid-year letter to shareholders, furnished under Regulation FD, that restates its first-half 2026 results: $14.0 million in revenue, up 116% from the first half of 2025, with 28 Breast Acoustic CT scanners shipped. The letter also cites 2026 revenue guidance of approximately $39 million, a $10 million underwritten public offering completed in the second quarter, and about $14.2 million in cash and restricted cash as of August 7, 2026, which matter to shareholders as indicators of growth and funding.
First-half 2026 revenue of $14.0 million, up 116% year over year
28 scanners shipped in the first half, double the same period in 2025
2026 revenue guidance of approximately $39 million; 2024 revenue was $4.9 million and 2025 revenue was $18.9 million
About $14.2 million in cash and restricted cash as of August 7, 2026, after a $10 million public offering in the second quarter
Arxis, Inc. closed its acquisition of Omnetics Connector Corporation on August 17, 2026, based on an agreed enterprise value of $770.0 million, subject to customary closing adjustments. At closing, the company issued 13,351,964 Class A common shares, about 3.1% of total common stock as of the closing date, and funded $8.0 million of cash escrow accounts. For shareholders, the deal adds a larger share count, with the new shares subject to lockup provisions.
Closing date: August 17, 2026; Omnetics will operate within the Electronic Components segment.
Agreed enterprise value of $770.0 million, subject to customary closing adjustments; combined purchase price multiple with the MagCanica acquisition is approximately 12x FY27 estimated adjusted EBITDA.
Issued 13,351,964 Class A common shares (about 3.1% of total common stock), subject to lockup provisions; $8.0 million funded into cash escrow accounts.
Entera Bio appointed Dr. Riccardo Paolo Camisasca as Chief Medical Officer effective August 18, 2026. The company said the hire comes ahead of the planned Phase 3 initiation of its EB613 oral osteoporosis candidate, which it describes as its most advanced product candidate.
Dr. Riccardo Paolo Camisasca appointed Chief Medical Officer, effective immediately on August 18, 2026
Dr. Camisasca has more than 30 years of experience, most recently as Global Head of Research & Development at Sumitomo Pharma Switzerland
Company plans to initiate a Phase 3 program for EB613, its oral PTH(1-34) tablet candidate for osteoporosis
Nano Dimension appointed Nadav Kidron as an independent director on August 16, 2026, effective immediately, with seats on the Audit and Compensation Committees. In a separate Regulation FD disclosure, the company said the 30-day exclusivity period under a non-binding term sheet with Infinite Epigenetics expired on July 15, 2026, and no definitive agreement has been reached.
Nadav Kidron appointed to the Board as a Class II director effective August 16, 2026, serving until the 2026 annual meeting
Kidron to serve on the Audit Committee and Compensation Committee; Board determined he is independent under Nasdaq rules
Exclusivity under the non-binding term sheet with Infinite Epigenetics, Inc. expired July 15, 2026
As of the filing date, the parties have not agreed on terms of a definitive agreement
Sypris Solutions reported second-quarter 2026 revenue of $30.3 million, down from $31.4 million a year earlier, and a net loss of $3.1 million, or $0.14 per share, compared with a loss of $2.1 million, or $0.09 per share, in the prior-year quarter. The company cited material availability issues and customer design changes at Sypris Electronics, and said orders rose 25% sequentially, with management expecting operations to improve through 2026.
Revenue was $30.3 million for the quarter ended July 5, 2026, versus $31.4 million a year earlier.
Sypris Electronics revenue fell to $15.5 million from $17.3 million, and it posted a gross loss of $0.8 million.
Net loss for the six months was $7.2 million, or $0.32 per share, compared with $3.0 million, or $0.13 per share, a year earlier.
Sypris Technologies revenue rose to $14.9 million from $14.1 million, and its gross profit increased to $2.7 million from $2.1 million.
Elauwit Connection reported second-quarter 2026 revenue of $2.9 million, down 46% from $5.3 million a year earlier, and a net loss of $3.1 million, compared with $0.9 million in the prior-year quarter. The company attributed the revenue decline to the timing of construction projects, which it expects to weight toward the second half of 2026, and said contracted units rose 33% year over year to 42,687.
Q2 2026 revenue was $2.9 million, down from $5.3 million in Q2 2025; six-month revenue was $7.3 million, down from $10.8 million.
Q2 2026 net loss was $3.1 million ($0.47 per share), compared with $0.9 million ($0.17 per share) a year earlier.
Contracted units reached 42,687 at June 30, 2026, up 33% year over year; billed units rose 163% to 22,967.
As of June 30, 2026, cash and cash equivalents were $1.2 million and total debt was $2.2 million.
On August 17, 2026, Cypherpunk agreed to buy mining equipment and hosting agreements from Moria Mining, LLC for $33,333,333, paid by issuing a pre-funded warrant to Winklevoss Treasury Investments, LLC (WTI) for 43,290,042 common shares. The deal adds Zcash mining capacity but also commits a large block of new shares to an affiliate of the seller, which shareholders should weigh against the expanded operations.
Purchase price is $33,333,333 for Z15 Pro mining machines with about 4.2 GSol/s of hashpower and related hosting agreements.
Payment is a pre-funded warrant for 43,290,042 shares at an exercise price of $0.001 per share; the company says this reflects a $0.77 per share common stock price.
Warrant exercise is capped at 19.99% beneficial ownership; the company will seek stockholder approval at its next annual meeting for issuance above 5,377,442 shares.
WTI, an affiliate of the seller, owns 19.9% of the company's stock and has appointed William McEvoy and Khing Oei to the board.
Home Depot reported second-quarter fiscal 2026 results for the quarter ended August 2, 2026, with net sales up 5.7% to $47.9 billion and GAAP diluted earnings per share of $4.79, compared with $4.58 a year earlier. The company reaffirmed its fiscal 2026 guidance, which includes IEEPA tariff refunds expected to partially offset unplanned fuel, energy, and other product input costs.
Net sales of $47.9 billion, up 5.7%; comparable sales up 1.7%, with U.S. comparable sales up 1.3%
GAAP diluted EPS of $4.79 vs. $4.58; adjusted diluted EPS of $4.92 vs. $4.68
Fiscal 2026 guidance reaffirmed, including adjusted diluted EPS growth of approximately flat to 4.0% from $14.69 in fiscal 2025
Quarterly operating margin of 14.3% vs. 14.5% a year earlier
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.